Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities-Reference-Cited by-同舟云学术

Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities

Published:2022-09 Issue:6 Volume:35 Page:554-572
ISSN:1755-1471
Container-title:Pigment Cell & Melanoma Research
language:en
Short-container-title:Pigment Cell Melanoma Res

Author:

Karz Alcida¹²,Dimitrova Maya²³,Kleffman Kevin¹²,Alvarez‐Breckenridge Christopher⁴,Atkins Michael B.⁵,Boire Adrienne⁶,Bosenberg Marcus⁷,Brastianos Priscilla⁸,Cahill Daniel P.⁹,Chen Qing¹⁰,Ferguson Sherise⁴^ORCID,Forsyth Peter¹¹^ORCID,Glitza Oliva Isabella C.¹²^ORCID,Goldberg Sarah B.¹³,Holmen Sheri L.¹⁴^ORCID,Knisely Jonathan P. S.¹⁵^ORCID,Merlino Glenn⁷,Nguyen Don X.¹⁶,Pacold Michael E.¹⁷,Perez‐Guijarro Eva⁷^ORCID,Smalley Keiran S. M.¹⁸^ORCID,Tawbi Hussein A.¹²,Wen Patrick Y.¹⁹,Davies Michael A.¹²^ORCID,Kluger Harriet M.¹³,Mehnert Janice M.²³,Hernando Eva¹²^ORCID

Affiliation:

1. Department of Pathology NYU Grossman School of Medicine New York USA

2. Interdisciplinary Melanoma Cooperative Group Perlmutter Cancer Center, NYU Langone Health New York USA

3. Department of Medicine NYU Grossman School of Medicine New York USA

4. Department of Neurosurgery The University of Texas MD Anderson Cancer Center Houston Texas USA

5. Georgetown‐Lombardi Comprehensive Cancer Center and Department of Oncology Georgetown University Medical Center Washington District of Columbia USA

6. Human Oncology and Pathogenesis Program, Department of Neurology Memorial Sloan Kettering Cancer Center New York USA

7. Laboratory of Cancer Biology and Genetics Center for Cancer Research NCI, NIH USA

8. MGH Cancer Center, Department of Medicine Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA

9. Department of Neurosurgery Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA

10. Immunology, Microenvironment and Metastasis Program The Wistar Institute Philadelphia Pennsylvania USA

11. Department of Neuro‐Oncology and Tumor Biology H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA

12. Department of Melanoma Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA

13. Department of Medicine (Medical Oncology) Yale School of Medicine New Haven Connecticut USA

14. Huntsman Cancer Institute and Department of Surgery University of Utah Health Sciences Center Salt Lake City Utah USA

15. Meyer Cancer Center and Department of Radiation Oncology Weill Cornell Medicine New York New York USA

16. Department of Pathology, Yale Cancer Center Yale University School of Medicine New Haven Connecticut USA

17. Department of Radiation Oncology NYU Langone Health and NYU Grossman School of Medicine New York New York USA

18. Department of Tumor Biology Moffitt Cancer Center and Research Institute Tampa Florida USA

19. Center for Neuro‐Oncology Dana‐Farber Cancer Institute, United States Boston Massachusetts USA

Publisher

Wiley

Subject

Dermatology,General Biochemistry, Genetics and Molecular Biology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pcmr.13059

Reference135 articles.

1. LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastases

2. Upfront Surgical Resection of Melanoma Brain Metastases Provides a Bridge Toward Immunotherapy-Mediated Systemic Control

3. Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition

4. Malignant melanoma and central nervous system metastases.Incidence, diagnosis, treatment and survival

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Letter to the Editor Regarding “Mutational Status and Clinical Outcomes Following Systemic Therapy with or without Focal Radiation for Resected Melanoma Brain Metastases”;World Neurosurgery;2024-08

2. Demographics aspects of brain and spine metastatic melanoma. Retrospective analysis in a single third-level center;World Neurosurgery: X;2024-04

3. Survival and treatment outcomes in patients with leptomeningeal disease from metastatic melanoma;Neuro-Oncology Practice;2024-03-30

4. Loss of AMPKα2 promotes melanoma tumor growth and brain metastasis;iScience;2023-06

5. Evolving Management of Stage IV Melanoma;American Society of Clinical Oncology Educational Book;2023-01